<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="letter"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Form Res</journal-id><journal-id journal-id-type="publisher-id">formative</journal-id><journal-id journal-id-type="index">27</journal-id><journal-title>JMIR Formative Research</journal-title><abbrev-journal-title>JMIR Form Res</abbrev-journal-title><issn pub-type="epub">2561-326X</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v10i1e79761</article-id><article-id pub-id-type="doi">10.2196/79761</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Letter</subject></subj-group></article-categories><title-group><article-title>Social Media Listening in Congenital Ichthyosis: Quantitative and Qualitative Findings</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Severino-Freire</surname><given-names>Ma&#x00EB;lla</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Granier Tournier</surname><given-names>C&#x00E9;line</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Malaab</surname><given-names>Jo&#x00EB;lle</given-names></name><degrees>MPH</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>S&#x00FC;&#x00DF;muth</surname><given-names>Kira</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gostynski</surname><given-names>Antoni</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hern&#x00E1;ndez-Mart&#x00ED;n</surname><given-names>&#x00C1;ngela</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Mazereeuw-Hautier</surname><given-names>Juliette</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref></contrib></contrib-group><aff id="aff1"><institution>Dermatology Department, Reference Center for Rare Skin Diseases, Centre Hospitalier Universitaire de Toulouse</institution><addr-line>24 chemin de Pouvourville</addr-line><addr-line>Toulouse</addr-line><country>France</country></aff><aff id="aff2"><institution>Kap Code</institution><addr-line>Paris</addr-line><country>France</country></aff><aff id="aff3"><institution>Department of Dermatology and Allergology, Campus of Medical School Berlin, Helios Klinikum Berlin-Buch</institution><addr-line>Berlin</addr-line><country>Germany</country></aff><aff id="aff4"><institution>Dermatology Department, Medical Center, Maastricht University</institution><addr-line>Maastricht</addr-line><country>The Netherlands</country></aff><aff id="aff5"><institution>Dermatology Department, Hospital Infantil Universitario Ni&#x00F1;o Jes&#x00FA;s</institution><addr-line>Madrid</addr-line><country>Spain</country></aff><aff id="aff6"><institution>Toulouse University, CNRS, Inserm, Institut Toulousain des Maladies Infectieuses et Inflammatoires</institution><addr-line>Toulouse</addr-line><country>France</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Mavragani</surname><given-names>Amaryllis</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Bestavros</surname><given-names>Samantha</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Juliette Mazereeuw-Hautier, MD, PhD, Dermatology Department, Reference Center for Rare Skin Diseases, Centre Hospitalier Universitaire de Toulouse, 24 chemin de Pouvourville, Toulouse, 31059, France, 33 0 33 5 67 77 8; <email>mazereeuw-hautier.j@chu-toulouse.fr</email></corresp></author-notes><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>18</day><month>3</month><year>2026</year></pub-date><volume>10</volume><elocation-id>e79761</elocation-id><history><date date-type="received"><day>27</day><month>06</month><year>2025</year></date><date date-type="rev-recd"><day>23</day><month>01</month><year>2026</year></date><date date-type="accepted"><day>27</day><month>01</month><year>2026</year></date></history><copyright-statement>&#x00A9; Ma&#x00EB;lla Severino-freire, C&#x00E9;line Granier Tournier, Jo&#x00EB;lle Malaab, Kira S&#x00FC;&#x00DF;muth, Antoni Gostynski, &#x00C1;ngela Hern&#x00E1;ndez-Mart&#x00ED;n, Juliette Mazereeuw-Hautier. Originally published in JMIR Formative Research (<ext-link ext-link-type="uri" xlink:href="https://formative.jmir.org">https://formative.jmir.org</ext-link>), 18.3.2026. </copyright-statement><copyright-year>2026</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://formative.jmir.org">https://formative.jmir.org</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://formative.jmir.org/2026/1/e79761"/><abstract><p>This study analyzed social media posts from patients with congenital ichthyosis and their caregivers across Europe and found that users, primarily young women, discussed hygiene care, psychological impact, therapeutic challenges, and lack of disease awareness. This allowed for the identification of unmet needs and potential actions to improve patients&#x2019; quality of life.</p></abstract><kwd-group><kwd>social media</kwd><kwd>congenital ichthyosis</kwd><kwd>quality of life</kwd><kwd>unmet needs</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Congenital ichthyoses (CI), recently classified within the group of epidermal differentiation disorders, are chronic skin conditions characterized by anomalies such as scaling or skin thickening, often associated with erythroderma [<xref ref-type="bibr" rid="ref1">1</xref>]. Quality of life is often impaired because of distressing symptoms, limited treatment efficacy, demanding skin care routines, social stigmatization, and a lack of awareness or education among both health care professionals and the general public [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>]. Consequently, patients often turn to the internet to find answers, connect with other patients, seek support, and access information. In this study, we analyzed the role of the internet in the lives of patients with CI to better understand their experiences and needs, with the goal of improving patient care and management.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Study Design and Population</title><p>This observational, retrospective, real-world study used data collected from social media posts by patients with CI and their caregivers. The messages, written in the local languages, were geolocated in four European countries: France, Germany, the Netherlands, and Spain. This study covered the period from January 2014 through January 2024.</p></sec><sec id="s2-2"><title>Data Extraction and Analysis</title><p>Data extraction and analysis methods are detailed in <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>. Briefly, data extraction was performed using the digital consumer intelligence platform Brandwatch to collect publicly available posts from public platforms and health-related forums (listed in <xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>) using a list of CI-related keywords defined by the investigators (listed in <xref ref-type="supplementary-material" rid="app3">Multimedia Appendix 3</xref>). Posts were cleaned by removing duplicates, irrelevant sources, nontarget languages, and messages that were too short or excessively long. A supervised machine-learning pipeline based on 2 sequential XGBoost classifiers was then applied to identify patient and caregiver experiences. Data analysis included manual extraction of demographic information when explicitly mentioned and identification of the main discussion themes using unsupervised topic modeling (biterm topic modeling), followed by human interpretation.</p></sec><sec id="s2-3"><title>Ethical Considerations</title><p>This study used data exclusively from publicly accessible sources, thereby excluding private groups and web pages. Ethical approval was not required, as users implicitly consented to the reuse of their data by posting on public platforms, and all the results were presented without identifiable information. Sensitive details, including names, usernames or handles, geographic locations, and other personal data, were deleted. To ensure compliance with the General Data Protection Regulation, the names of treatments were anonymized and replaced with a generic [TREATMENT] placeholder in the messages.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><p>A total of 5175 messages were initially collected. After removing off-topic posts, 4302 messages from 2182 unique users remained. Following the application of the patient and caregiver classification algorithm, 201 messages from 169 users were identified. Of these users, 90 were patients and 79 were caregivers.</p><p>The characteristics of the users and their posts are reported in <xref ref-type="table" rid="table1">Table 1</xref>. Of the 169 users, 110 (65%) were women, with a mean age of 36 years (SD 6.1; range 21&#x2010;57). Among the 43 identified social media networks (<xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>), the most frequently used platforms were Twitter (31.3%, 63/201), Doctissimo (18.4%, 25/201), and Facebook (7.5%, 15/201). The 5 main discussion topics, in decreasing order of frequency, were hygiene care (31%, 63/201), psychological impact of the disease (18%, 37/201), disease characteristics (17%, 35/201), contact tracing (13%, 27/201), and treatments or lack of awareness of the disease (10%, 20/201). Content and examples of posts for each topic are provided in <xref ref-type="table" rid="table2">Table 2</xref>.</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Characteristics of the users (N=169) and posts (N=201).</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Characteristics</td><td align="left" valign="bottom">Values</td></tr></thead><tbody><tr><td align="left" valign="top"><bold>Demographic data of the users, n (%)</bold></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Users</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Patients</td><td align="left" valign="top">90 (53.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Caregivers</td><td align="left" valign="top">79 (46.7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Gender</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Female</td><td align="left" valign="top">110 (65.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Male</td><td align="left" valign="top">27 (16)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Not mentioned</td><td align="left" valign="top">32 (18.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Age (y)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>18-19</td><td align="left" valign="top">0 (0)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>20-29</td><td align="left" valign="top">27 (16)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>30-39</td><td align="left" valign="top">105 (62.1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>40-49</td><td align="left" valign="top">30 (17.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>50-59</td><td align="left" valign="top">3 (1.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>60 and older</td><td align="left" valign="top">0 (0)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Not mentioned</td><td align="left" valign="top">4 (2.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Mean age (SD); range (y)</td><td align="left" valign="top">36 (6.1); 21&#x2010;57</td></tr><tr><td align="left" valign="top"><bold>Characteristics of the posts, n (%)</bold></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Topics of discussion</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Hygiene care</td><td align="left" valign="top">63 (31.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Psychological impact</td><td align="left" valign="top">37 (18.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Characteristics of the disease</td><td align="left" valign="top">35 (17.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Request for contact and discussions with ichthyosis patients or families</td><td align="left" valign="top">27 (13.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Information on available treatments and feedback</td><td align="left" valign="top">20 (10.0)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other<sup><xref ref-type="table-fn" rid="table1fn1">a</xref></sup></td><td align="left" valign="top">19 (9.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Social media platforms</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Twitter</td><td align="left" valign="top">63 (31.3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Doctissimo</td><td align="left" valign="top">25 (12.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Facebook</td><td align="left" valign="top">15 (7.5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other<sup><xref ref-type="table-fn" rid="table1fn2">b</xref></sup></td><td align="left" valign="top">98 (48.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Countries</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Germany</td><td align="left" valign="top">76 (37.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>France</td><td align="left" valign="top">58 (28.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Spain</td><td align="left" valign="top">54 (26.9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>The Netherlands</td><td align="left" valign="top">13 (6.5)</td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><p><sup>a</sup>Includes doubts about the diagnosis and questions from parents about their child&#x2019;s case.</p></fn><fn id="table1fn2"><p><sup>b</sup>The complete list of social media platforms analyzed is presented in <xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref>.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>Description of the 5 main discussion topics and examples of posts</p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="top">Topics of discussion</td><td align="left" valign="top">Examples of posts</td></tr></thead><tbody><tr><td align="left" valign="top"><bold>Hygiene care</bold></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><list list-type="bullet"><list-item><p>Description of their skin conditions and the type of ichthyosis they have.</p></list-item><list-item><p>Which skincare products (creams, lotions, soaps) improve their skin.</p></list-item><list-item><p>Their routines based on personal experience or dermatologist recommendations.</p></list-item><list-item><p>Experience with different products.</p></list-item><list-item><p>Seasonal influence.</p></list-item></list></td><td align="left" valign="top"><list list-type="bullet"><list-item><p><italic>I may have a solution that can work..., it depends on the type of ichthyosis you have. There&#x2019;s a cream that could help you,....</italic></p></list-item><list-item><p><italic>Our son suffers from ichthyosis. In winter, the skin is in really bad shape, but in summer we have it under control.</italic></p></list-item></list></td></tr><tr><td align="left" valign="top"><bold>Psychological impact</bold></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><list list-type="bullet"><list-item><p>People&#x2019;s perception was a major concern of patients.</p></list-item><list-item><p>Patients felt burdened by how others looked at them outside their family circle.</p></list-item><list-item><p>Patients often had to explain their visibly different skin; this was especially difficult for adolescents and young adults, who struggled with feeling &#x201C;different.&#x201D;</p></list-item><list-item><p>Caregivers, particularly parents, were also affected by others&#x2019; reactions and questions. In some cases, these encounters felt like harassment and created a strong sense of injustice.</p></list-item></list></td><td align="left" valign="top"><list list-type="bullet"><list-item><p><italic>I&#x2019;ve heard advice and comments all my life about my ichthyosis and I&#x2019;m just sick of it.</italic></p></list-item><list-item><p><italic>Have you ever been reported to social services for lack of knowledge of this disease, on the pretext that your children are dirty? In my case, I have 2 children with ichthyosis and I feel harassed and tired of fighting against a steel wall...</italic></p></list-item></list></td></tr><tr><td align="left" valign="top"><bold>Characteristics of the disease</bold></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><list list-type="bullet"><list-item><p>Physical burden was a key theme across many posts.</p></list-item><list-item><p>Patients and caregivers described skin lesion location, appearance, and symptoms, and functional issues such as the inability to perspire or difficulty regulating body temperature.</p></list-item><list-item><p>In some cases, skin lesions were highly visible and disruptive to daily life.</p></list-item><list-item><p>Caregivers often expressed a sense of helplessness in managing these symptoms.</p></list-item></list></td><td align="left" valign="top"><list list-type="bullet"><list-item><p><italic>My skin is dying with the cold + humidity and I&#x2019;m in agony. Damn Ichthyosis.</italic></p></list-item><list-item><p><italic>I was scratching and bleeding because the itching was so much worse than anything else.</italic></p></list-item></list></td></tr><tr><td align="left" valign="top"><bold>Contact tracing</bold></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><list list-type="bullet"><list-item><p>Need for connection and information.</p></list-item><list-item><p>Seeking advice from others due to unpreparedness of dealing with child&#x2019;s condition.</p></list-item><list-item><p>Dissatisfaction with medical advice led them to prefer peer feedback.</p></list-item><list-item><p>Created blogs to share experiences, bridge the information gap, and simply be heard.</p></list-item><list-item><p>Seeking emotional support from persons who understand and do not judge.</p></list-item></list></td><td align="left" valign="top"><list list-type="bullet"><list-item><p><italic>Hello, after much research we have been diagnosed with ichthyosis in our three-month-old adopted baby. Now, there are a lot of questions in the room, does anyone have any experience in this area?</italic></p></list-item><list-item><p><italic>I am the mother of a little boy who is 10 1/2 months old. He has Netherton syndrome and was hospitalized until 8 1/2 months....I would like to hear from parents who know about this disease and who can tell me about their daily lives..., parents who could give me advice, etc....to help my baby. Thank you to everyone.</italic></p></list-item></list></td></tr><tr><td align="left" valign="top"><bold>Treatments and lack of awareness of the disease</bold></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"><list list-type="bullet"><list-item><p>Through their experiences&#x2014;both positive and negative&#x2014;patients and caregivers shared opinions and reported on various treatments they have tried or been offered.</p></list-item><list-item><p>Many highlighted the general lack of awareness about the disease among those around them.</p></list-item><list-item><p>This lack of understanding was reported as a challenge in daily life, including interactions with family, friends, schools, and nurseries.</p></list-item><list-item><p>The main issue, from the patient and caregiver perspective, is the limited recognition of the condition by some health care professionals, which can strain the relationships between patients, caregivers, and doctors.</p></list-item></list></td><td align="left" valign="top"><list list-type="bullet"><list-item><p><italic>Hello my child has been suffering from second degree ichthyosis since birth and the only thing that is always suggested is cortisone....side effects are severe and unacceptable...but there is virtually no alternative for my child.</italic></p></list-item><list-item><p><italic>When my son went to nursery, one of the nursery nurses thought he had spots and tried to rub his legs. When she told me, I explained to her that it was ichthyosis and she had never heard of it.</italic></p></list-item></list></td></tr></tbody></table></table-wrap></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><p>This first European study on social media posts from users with CI and their caregivers found that users, predominantly young women on Twitter, primarily discussed hygiene care, therapeutic issues, psychological impact, and low disease awareness among the public and health care professionals.</p><p>Regarding the study population, we observed a predominance of young female users, consistent with the general tendency for women to seek health information online [<xref ref-type="bibr" rid="ref4">4</xref>], and with the findings of Voillot et al [<xref ref-type="bibr" rid="ref5">5</xref>] in atopic dermatitis (AD), suggesting both general and disease-specific trends.</p><p>Hygiene care and therapeutic issues were also key discussion topics for patients with AD, along with peer support [<xref ref-type="bibr" rid="ref5">5</xref>]. In contrast, lack of disease awareness was specific to CI, a rare condition, and, together with the psychological impact, had already been highlighted in our 2012 focus group study [<xref ref-type="bibr" rid="ref2">2</xref>]. Topics such as romantic relationships and sexual health, reported by van Veen [<xref ref-type="bibr" rid="ref3">3</xref>] and a shared patient voices report [<xref ref-type="bibr" rid="ref6">6</xref>], were absent in our study, either because patients did not raise them or because they were removed as sensitive information.</p><p>Inadequate management, linked to gaps in health care professionals&#x2019; knowledge or interest and limited effective therapies, was expressed more strongly online, possibly due to the anonymity of social media. Unlike the 2012 qualitative study [<xref ref-type="bibr" rid="ref2">2</xref>], no positive aspects of living with CI were reported, suggesting that social media mainly serves as a space to voice challenges rather than share positive experiences.</p><p>This study has several limitations, including the small number of posts due to the rarity of the disease, the exclusion of data from private groups and Instagram (<xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref>), and the possibility that it did not capture the needs and experiences of all patients, as those uncomfortable with the internet may not have participated.</p><p>In conclusion, this study highlights the needs of patients with CI that may guide improved management. Providing information, particularly through online tools developed in collaboration with patient associations, rare disease networks [<xref ref-type="bibr" rid="ref7">7</xref>], or digital education programs such as our e-TPE (digital therapeutic patient education) is essential [<xref ref-type="bibr" rid="ref8">8</xref>]. Public education also remains important and could be promoted through national society campaigns. The growing use of artificial intelligence, as recently explored in AD, is likely to transform how patients seek information [<xref ref-type="bibr" rid="ref8">8</xref>-<xref ref-type="bibr" rid="ref10">10</xref>]. Psychological support should be routinely offered to patients and caregivers, and research should continue to focus on developing new therapies. Collectively, these measures can help enhance patients&#x2019; quality of life.</p></sec></body><back><notes><sec><title>Funding</title><p>This study was funded by ERN-Skin (European Reference Networks for Rare Skin Diseases).</p></sec><sec><title>Data Availability</title><p>All data generated or analyzed during this study are included in this published article and its supplementary information files.</p></sec></notes><fn-group><fn fn-type="con"><p>Conceptualization: JM-H (lead), KS (equal), AG (equal), &#x00C1;H-M (equal)</p><p>Formal analysis &#x2013; JM</p><p>Funding acquisition: JM-H</p><p>Resources: JM</p><p>Supervision: JM-H</p><p>Validation: &#x00C1;H-M</p><p>Visualization: MS-F</p><p>Writing &#x2013; original draft: JM-H (lead), CGT (equal)</p><p>Writing &#x2013; review &#x0026; editing: CGT (equal), JM-H (equal), MS-F (supporting), JM (supporting), KS (supporting), AG (supporting), &#x00C1;H-M (supporting)</p></fn><fn fn-type="conflict"><p>MSF has been an investigator for Abbvie, AstraZeneca, COREvitas, Incyte, LEO Pharma, Novartis, and Sanofi Regeneron, and an expert for Abbvie, Almirall, BMS, Incyte, Krystal and Sanofi Regeneron. JM took part in drafting some parts of the manuscript/editing and is employed by Kap Code. KS received a research funding award from Berliner Dermatologische Gesellschaft (BDG), has been part of the Clinician Scientist Program from the Deutsche Dermatologische Gesellschaft (BDG) und Arbeitsgemeinschaft Dermatologische Forschung (ADF), has been a medical advisor for Nia Health GmbH and Thieme Referenz Dermatologie, has been part of the Dermatologisches Konsil from RG &#x00C4;rztefortbildung, and received a support from ERN-skin for a guideline meeting. AHM has been a consultant for Sanofi, ViatriS, L'Or&#x00E9;al, LETI Pharma GmbH, Beiersdorf, and Alexion Pharma, and participated on a Data Safety Monitoring Board and Advisory Board for Sanofi, ViatriS, L'Or&#x00E9;al, and Galderma. JMH has been an investigator for Abbvie, Amryt Research Limited, Amgen, AstraZeneca, Celg&#x00E8;ne, COREvitas, Incyte, InMed Pharmaceuticals Inc, LEO Pharma, Lilly, Mayne, Novartis, Pierre Fabre, Pfizer, RHEACELL GmbH &#x0026; Co KG, Sanofi, Scioderm Inc, Timber Pharmaceuticals, and Urgo, and an expert for Abbvie, Almirall, Incyte, Krystal, Pfizer, and Sanofi. The other authors have no conflict of interest to declare.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">AD</term><def><p>atopic dermatitis</p></def></def-item><def-item><term id="abb2">CI</term><def><p>congenital ichthyosis</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hern&#x00E1;ndez-Mart&#x00ED;n</surname><given-names>&#x00C1;</given-names> </name><name name-style="western"><surname>Paller</surname><given-names>AS</given-names> </name><name name-style="western"><surname>Sprecher</surname><given-names>E</given-names> </name><etal/></person-group><article-title>A proposal for a new pathogenesis-guided classification for inherited epidermal differentiation disorders</article-title><source>Br J Dermatol</source><year>2025</year><month>08</month><day>18</day><volume>193</volume><issue>3</issue><fpage>544</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1093/bjd/ljaf065</pub-id><pub-id pub-id-type="medline">40155206</pub-id></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mazereeuw-Hautier</surname><given-names>J</given-names> </name><name name-style="western"><surname>Dreyfus</surname><given-names>I</given-names> </name><name name-style="western"><surname>Barbarot</surname><given-names>S</given-names> </name><etal/></person-group><article-title>Factors influencing quality of life in patients with inherited ichthyosis: a qualitative study in adults using focus groups</article-title><source>Br J Dermatol</source><year>2012</year><month>03</month><volume>166</volume><issue>3</issue><fpage>646</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2133.2011.10701.x</pub-id><pub-id pub-id-type="medline">22014001</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Veen</surname><given-names>FCAP</given-names> </name><name name-style="western"><surname>Rossel</surname><given-names>V</given-names> </name><name name-style="western"><surname>Steijlen</surname><given-names>PM</given-names> </name><etal/></person-group><article-title>The perceived quality of life in adult patients with inherited ichthyosis: a qualitative interview study</article-title><source>Br J Dermatol</source><year>2025</year><month>02</month><day>18</day><volume>192</volume><issue>3</issue><fpage>553</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1093/bjd/ljae436</pub-id><pub-id pub-id-type="medline">39506357</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Fox</surname><given-names>S</given-names> </name></person-group><article-title>Profiles of health information seekers</article-title><source>Pew Research Center</source><year>2011</year><access-date>2026-01-23</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.pewresearch.org/internet/2011/02/01/profiles-of-health-information-seekers/">https://www.pewresearch.org/internet/2011/02/01/profiles-of-health-information-seekers/</ext-link></comment></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Voillot</surname><given-names>P</given-names> </name><name name-style="western"><surname>Riche</surname><given-names>B</given-names> </name><name name-style="western"><surname>Portafax</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Social media platforms listening study on atopic dermatitis: quantitative and qualitative findings</article-title><source>J Med Internet Res</source><year>2022</year><month>01</month><day>28</day><volume>24</volume><issue>1</issue><fpage>e31140</fpage><pub-id pub-id-type="doi">10.2196/31140</pub-id><pub-id pub-id-type="medline">35089160</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Veen</surname><given-names>FCAP</given-names> </name><name name-style="western"><surname>Sprecher</surname><given-names>E</given-names> </name><name name-style="western"><surname>Schwartz</surname><given-names>J</given-names> </name><etal/></person-group><article-title>The importance of shared patient voices in advancing science for genodermatoses on a global scale</article-title><source>J Invest Dermatol</source><year>2025</year><month>09</month><volume>145</volume><issue>9</issue><fpage>2127</fpage><lpage>2130</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2025.05.027</pub-id><pub-id pub-id-type="medline">40600863</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="web"><article-title>Documents for patients</article-title><source>ERN-Skin (European Reference Networks for Rare Skin Diseases)</source><access-date>2026-02-19</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://ern-skin.eu/documents_patients/">https://ern-skin.eu/documents_patients/</ext-link></comment></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sulejmani</surname><given-names>P</given-names> </name><name name-style="western"><surname>Negris</surname><given-names>O</given-names> </name><name name-style="western"><surname>Aoki</surname><given-names>V</given-names> </name><etal/></person-group><article-title>A large language model artificial intelligence for patient queries in atopic dermatitis</article-title><source>J Eur Acad Dermatol Venereol</source><year>2024</year><month>06</month><volume>38</volume><issue>6</issue><fpage>e531</fpage><lpage>e535</lpage><pub-id pub-id-type="doi">10.1111/jdv.19737</pub-id><pub-id pub-id-type="medline">38168874</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ayers</surname><given-names>JW</given-names> </name><name name-style="western"><surname>Poliak</surname><given-names>A</given-names> </name><name name-style="western"><surname>Dredze</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Comparing physician and artificial intelligence chatbot responses to patient questions posted to a public social media forum</article-title><source>JAMA Intern Med</source><year>2023</year><month>06</month><day>1</day><volume>183</volume><issue>6</issue><fpage>589</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1001/jamainternmed.2023.1838</pub-id><pub-id pub-id-type="medline">37115527</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sulejmani</surname><given-names>P</given-names> </name><name name-style="western"><surname>Negris</surname><given-names>O</given-names> </name><name name-style="western"><surname>Aoki</surname><given-names>V</given-names> </name><etal/></person-group><article-title>The global reach of artificial intelligence in atopic dermatitis: the quality and reliability of ChatGPT responses in 8 languages</article-title><source>JAAD Int</source><year>2024</year><month>12</month><volume>17</volume><fpage>158</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.jdin.2024.08.013</pub-id><pub-id pub-id-type="medline">40104109</pub-id></nlm-citation></ref></ref-list><app-group><supplementary-material id="app1"><label>Multimedia Appendix 1</label><p>Supplementary methods.</p><media xlink:href="formative_v10i1e79761_app1.docx" xlink:title="DOCX File, 19 KB"/></supplementary-material><supplementary-material id="app2"><label>Multimedia Appendix 2</label><p>Social media used in the different countries.</p><media xlink:href="formative_v10i1e79761_app2.docx" xlink:title="DOCX File, 14 KB"/></supplementary-material><supplementary-material id="app3"><label>Multimedia Appendix 3</label><p>Query used for extraction on Brandwatch.</p><media xlink:href="formative_v10i1e79761_app3.docx" xlink:title="DOCX File, 14 KB"/></supplementary-material></app-group></back></article>